The law of unforeseen consequences is ever-present. Especially when two great ideas clash.
Take for instance Population Health Management (a great idea that relies on profiling, marketing new services and great communication with patients) and privacy and data legislation (a great idea that prevents automated profiling and electronic marketing without explicit consent).
Cegedim UK announces the brand merger of BlueBay Medical Systems and Vision (In Practice Systems Ltd), following the acquisition of BlueBay Medical by Cegedim UK in 2017. For the last two years, BlueBay and Vision have shared their technology, resources and expertise to support GP practices, CCGs and Health Boards. As of the 1st of January 2019, the brands have come together under the Vision banner to inspire more ubiquity, with the aim of improving the patient experience.
Vision gets asked to sponsor lots of events, but we’re picky. It is important to us that we move the primary healthcare agenda on and provide practical support and help the NHS to improve. That’s why we’ve decided to exhibit at the Towards Population Health Systems: What Next? at the King’s Fund on April 30th.
The move toward population health management is reinforced by commitments set out in the NHS long-term plan, but how should health systems respond?
Russell Blackmore, Commercial Director of Vision, explains why Vision’s first secondary care customer demonstrates the company’s commitment to innovation.
Getting new customers is always exciting but helping University Hospital Southampton (UHS) NHS Foundation Trust replace its old Map of Medicine pathway tool with Vision’s Outcomes Manager is also a landmark first step for Vision into the secondary care sector.
Data lakes are being sold as the solution to delivering population health programmes but if you are a GP the best starting place might be your own data pool.
Every GP practice in the country is sitting on a pool of data that they have inputted, understand and trust. For a GP that might be a better starting point on their population health journey than a data lake. For professionals who are understandably cautious, a practice’s own data has the advantage of being populated with real-time information, from known contributors, with the ability to verify accuracy and completeness immediately.
When Owen Epstein and Mike Stein created Map of Medicine at the Royal Free Hospital in 2000, it represented a revolution in clinical pathway creation and dissemination. But now it is no more; general practices and hospitals around the UK are searching for a replacement.
When it was announced in July 2018 that Map of Medicine was withdrawing from the market and discontinuing support for more than 420 digital clinical decision pathways, GPs and hospital consultants went looking to find a new solution.
Ever since Map of Medicine was integrated into the National Programme for IT the tool has helped GPs and hospital doctors reduce poor referrals, inappropriate tests and flawed patient journeys.
People in the UK are living with chronic illnesses but not getting appropriate treatment. Without intervention, patients face worsening health with irreversible damage. For some, the outcome will be worse than this. No one is to blame for these undiagnosed conditions. The NHS is not at fault. So what is the problem, and what can you do about it?
Yesterday, The Kings Fund hosted an online event about transforming healthcare at scale. The theme was to explore the advantages of a population level approach to healthcare:
It costs the UK £8 billion a year to treat the preventable complications of diabetes. Over 4 million people are living with diabetes in the UK. Better self-management will make an enormous difference to a patient's well being. If these patients can learn how to manage their illness better, they will reduce the strain on GP practices.
When you treat a patient with diabetes, you can issue them an 'information prescription'.